Related Experiment Video

Updated: Nov 15, 2025

Continuous Manual Exchange Transfusion for Patients with Sickle Cell Disease: An Efficient Method to Avoid Iron Overload
05:23

Continuous Manual Exchange Transfusion for Patients with Sickle Cell Disease: An Efficient Method to Avoid Iron Overload

Published on: March 14, 2017

19.9K

[Management of pediatric hematological diseases during the COVID-19 pandemic]

Tomoko Iehara1, Daisuke Hasegawa2

  • 1Department of Pediatrics Graduate School of Medical Science, Kyoto Prefectural University of Medicine.

[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology
|March 8, 2021
PubMed

Insights

Preventing COVID-19 in pediatric cancer and hematology patients requires strict hygiene and avoiding crowds. Early detection of complications and personalized treatment are crucial, alongside addressing resource limitations and patient fears.

Area of Science:

  • Pediatric Hematology Oncology
  • Infectious Disease Control

Background:

  • Pediatric patients with hematological diseases and cancer are at high risk for severe COVID-19.
  • Preventing nosocomial infections during hospitalization is critical for this vulnerable population.

Purpose of the Study:

  • To outline preventive strategies for COVID-19 in pediatric hematology-oncology patients.
  • To discuss the management of COVID-19 complications and treatment individualization in these patients.
  • To highlight challenges including patient-related fears and resource limitations.

Main Methods:

  • Review of current recommendations for infection prevention.
  • Discussion of clinical considerations for managing COVID-19 in immunocompromised children.
  • Emphasis on the need for clear communication and information dissemination.

Main Results:

  • Key preventive measures include avoiding crowds, mask-wearing, and hand hygiene.
  • Management requires assessing COVID-19 complications and tailoring treatment to high-risk conditions.
  • Fear of infection can lead to delayed medical care, worsening outcomes.

Conclusions:

  • Comprehensive strategies are needed to protect pediatric hematology-oncology patients from COVID-19.
  • Addressing patient/parental concerns and ensuring resource availability are vital for effective care.
  • Personalized treatment plans are essential for managing COVID-19 in this population.

Keywords:
COVID-19Hematological diseasePediatric patientsSARS-CoV-2

More Related Videos

Isolation Method for Long-Term and Short-Term Hematopoietic Stem Cells06:41

Isolation Method for Long-Term and Short-Term Hematopoietic Stem Cells

Published on: May 19, 2023

2.2K
Author Spotlight: Unveiling the Polyfunctionality and Heterogeneity in Immune Responses09:43

Author Spotlight: Unveiling the Polyfunctionality and Heterogeneity in Immune Responses

Published on: March 8, 2024

2.1K

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
101
Bone Marrow Sampling and Transplants01:22

Bone Marrow Sampling and Transplants

Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
634
Regulation of Hematopoietic Stem Cells01:01

Regulation of Hematopoietic Stem Cells

All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
3.6K
Overview of Hematopoiesis01:20

Overview of Hematopoiesis

Hematopoiesis, or blood cell production, is a vital biological process that begins early in embryonic development and continues throughout life. This process generates the various types of cells found in blood, including red blood cells, white blood cells, and platelets from hematopoietic stem cells (HSCs).
Developmental Phases of Hematopoiesis
Initially, HSCs are formed in the embryonic yolk sac, a critical site for early blood cell production. These stem cells subsequently migrate to other...
6.4K
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
118
Hematopoiesis01:21

Hematopoiesis

The process of blood cell formation is called hematopoiesis. Hematopoiesis starts early during development, on the seventh day of embryogenesis. This phase of hematopoiesis is called the primitive wave, wherein the extraembryonic yolk sac allows the production of erythroid cells and endothelial cells from a common precursor called hemangioblast. The erythroid cells provide oxygen to support the growth of the rapidly dividing embryo. Hemangioblasts later develop into hematopoietic stem cells or...
7.7K